AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34781008 — intervention group
Group type: EXPERIMENTAL
Intervention: MOCA + 3% POL liquid (3% group)
Number of subjects: 364
Study 34781008 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (2% and 3%)
Number of subjects: 364
Study 34781008 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% group
Number of subjects: 364
Study 34781008 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 364
Study 33789470 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual education plus an additional module on realistic expectations
Number of subjects: 204
Study 33789470 — intervention group
Group type: COMPARATOR
Intervention: Usual preoperative education (control group)
Number of subjects: 204
Study 33212355 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall Prevention intervention (n=58)
Number of subjects: 118
Study 33212355 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=60)
Number of subjects: 118
Study 33203383 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphological features and ISSR‐based DNA markers analysis
Number of subjects: 38
Study 34689669 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental video
Number of subjects: 345
Study 34689669 — intervention group
Group type: EXPERIMENTAL
Intervention: NCAA handout
Number of subjects: 345
Study 34689669 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment control video
Number of subjects: 345
Study 33653685 — intervention group
Group type: EXPERIMENTAL
Intervention: High oxygen protocol (6-8 L/min by face mask)
Number of subjects: 40872
Study 33653685 — intervention group
Group type: COMPARATOR
Intervention: Low oxygen protocol (Oxygen only if SpO2 < 90%)
Number of subjects: 40872
Study 33653685 — intervention group
Group type: EXPERIMENTAL
Intervention: High oxygen protocol (for STEMI patients)
Number of subjects: 40872
Study 33653685 — intervention group
Group type: COMPARATOR
Intervention: Low oxygen protocol (for STEMI patients)
Number of subjects: 40872
Study 33653685 — intervention group
Group type: EXPERIMENTAL
Intervention: High oxygen protocol (for non-STEMI patients)
Number of subjects: 40872
Study 33653685 — intervention group
Group type: COMPARATOR
Intervention: Low oxygen protocol (for non-STEMI patients)
Number of subjects: 40872
Study 32202620 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised warning statements
Number of subjects: 2505
Study 32202620 — intervention group
Group type: COMPARATOR
Intervention: TCA statements
Number of subjects: 2505
Study 36261056 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training of the non-hemiplegic side (NHS)
Number of subjects: 139
Study 36261056 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation training (control)
Number of subjects: 139
Study 33542437 — intervention group
Group type: COMPARATOR
Intervention: lopinavir-ritonavir (LPV/r) for 1 year
Number of subjects: 553
Study 33542437 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine (3TC) for 1 year
Number of subjects: 553
Study 35025152 — intervention group
Group type: EXPERIMENTAL
Intervention: SUN's abdominal acupuncture
Number of subjects: 80
Study 35025152 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 80
Study 33866729 — intervention group
Group type: COMPARATOR
Intervention: Transconjunctival route repair
Number of subjects: 78
Study 33866729 — intervention group
Group type: EXPERIMENTAL
Intervention: Subciliary route repair
Number of subjects: 78
Study 34734297 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated implant (TiNiN)
Number of subjects: 118
Study 34734297 — intervention group
Group type: COMPARATOR
Intervention: Standard implant (CoCr)
Number of subjects: 118
Study 34488744 — intervention group
Group type: EXPERIMENTAL
Intervention: A-NiTi archwires
Number of subjects: 88
Study 34488744 — intervention group
Group type: COMPARATOR
Intervention: Cu-NiTi archwires
Number of subjects: 88
Study 32235930 — intervention group
Group type: EXPERIMENTAL
Intervention: Underfeeding
Number of subjects: 27
Study 32235930 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vancomycin
Number of subjects: 27
Study 32235930 — intervention group
Group type: COMPARATOR
Intervention: Overfeeding
Number of subjects: 27
Study 32235930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 32235930 — intervention group
Group type: EXPERIMENTAL
Intervention: Underfeeding and Oral vancomycin
Number of subjects: 27
Study 32235930 — intervention group
Group type: EXPERIMENTAL
Intervention: Underfeeding and Overfeeding
Number of subjects: 27
Study 35995733 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB with 20 mL of 0.5% ropivacaine
Number of subjects: 70
Study 35995733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ACB)
Number of subjects: 70
Study 33785933 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) therapy
Number of subjects: 20
Study 33785933 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 20
Study 32229139 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g dark chocolate containing 410 mg of flavanols per day
Number of subjects: 100
Study 32229139 — intervention group
Group type: COMPARATOR
Intervention: 50 g dark chocolate containing 86 mg of flavanols per day
Number of subjects: 100
Study 32229139 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 35452108 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week weight loss and lifestyle intervention (nutritional behavior change, aerobic exercise, sleep hygiene, alcohol and tobacco cessation) combined with usual care (CPAP therapy)
Number of subjects: 89
Study 35452108 — intervention group
Group type: COMPARATOR
Intervention: usual care (CPAP therapy)
Number of subjects: 89
Study 33455786 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-CP ground starter feed mixed with alkali-processed wheat straw (HP-PWS)
Number of subjects: 60
Study 33455786 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-CP ground starter feed (23.5% CP)
Number of subjects: 60
Study 33455786 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-CP ground starter feed
Number of subjects: 60
Study 33455786 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed wheat straw (PWS) mixed with starter feed
Number of subjects: 60
Study 33455786 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed wheat straw (PWS)
Number of subjects: 60
Study 33455786 — intervention group
Group type: COMPARATOR
Intervention: Lower-CP ground starter feed mixed with unprocessed wheat straw (LP-WS)
Number of subjects: 60
Study 33455786 — intervention group
Group type: COMPARATOR
Intervention: Lower-CP ground starter feed mixed with alkali-processed wheat straw (LP-PWS)
Number of subjects: 60
Study 33455786 — intervention group
Group type: COMPARATOR
Intervention: Higher-CP ground starter feed mixed with unprocessed wheat straw (HP-WS)
Number of subjects: 60
Study 33263352 — intervention group
Group type: EXPERIMENTAL
Intervention: Music tuned to 432 Hz
Number of subjects: 12
Study 33263352 — intervention group
Group type: COMPARATOR
Intervention: Music tuned to 440 Hz
Number of subjects: 12
Study 35101094 — intervention group
Group type: EXPERIMENTAL
Intervention: BioBlock nasal spray (intervention)
Number of subjects: 0
Study 35101094 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray (control)
Number of subjects: 0
Study 34446480 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS combined with computer‐assisted cognitive training
Number of subjects: 36
Study 34446480 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS over bilateral temporal cortex (BTC)
Number of subjects: 36
Study 34446480 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 36
Study 34446480 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 36
Study 36467457 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 100
Study 36467457 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux‐en‐Y gastric bypass (RYGB)
Number of subjects: 100
Study 35273566 — intervention group
Group type: EXPERIMENTAL
Intervention: LT3 monotherapy for 12 weeks
Number of subjects: 59
Study 35273566 — intervention group
Group type: COMPARATOR
Intervention: LT4 monotherapy for 12 weeks
Number of subjects: 59
Study 35273566 — intervention group
Group type: EXPERIMENTAL
Intervention: LT3 treatment
Number of subjects: 59
Study 35273566 — intervention group
Group type: COMPARATOR
Intervention: LT3 vs LT4
Number of subjects: 59
Study 36182638 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip weakness group (grip strength < 18 kg)
Number of subjects: 90
Study 33250038 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT)
Number of subjects: 182
Study 33250038 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 182
Study 33250038 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT) with CT selection
Number of subjects: 182
Study 33250038 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT) with MRI selection
Number of subjects: 182
Study 32700828 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 0
Study 35164833 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice reinforced by weekly supportive phone/email support for 4 weeks.
Number of subjects: 0
Study 35164833 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium supplement prescribed if no increase in potassium intake after 4 weeks.
Number of subjects: 0
Study 35164833 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice and potassium supplement.
Number of subjects: 0
Study 35164833 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent measurements of sodium intake, blood pressure, participant satisfaction, and safety measures.
Number of subjects: 0
Study 33774529 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipids
Number of subjects: 64
Study 33774529 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 64
Study 33774529 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 64
Study 33774529 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated embryo transfers
Number of subjects: 64
Study 33774529 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-treated transfers
Number of subjects: 64
Study 33774529 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid-treated transfers
Number of subjects: 64
Study 34676808 — intervention group
Group type: EXPERIMENTAL
Intervention: CPS low group in model 1
Number of subjects: 490
Study 34676808 — intervention group
Group type: EXPERIMENTAL
Intervention: CPS 0, 1 and 2 in model 2
Number of subjects: 490
Study 34020136 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-Strengths-Oriented Therapeutic Conversations (CO-SOTC) sessions, 3 sessions
Number of subjects: 120
Study 34715059 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age (not specifically treated as an intervention, but analyzed as a variable)
Number of subjects: 491
Study 34715059 — intervention group
Group type: EXPERIMENTAL
Intervention: History of acute mountain sickness
Number of subjects: 491
Study 34715059 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-year-old dichotomy
Number of subjects: 491
Study 34715059 — intervention group
Group type: EXPERIMENTAL
Intervention: Decade of life
Number of subjects: 491
Study 32501812 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal treatment (specifics not provided)
Number of subjects: 0
Study 34332537 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Exercise (TCE)
Number of subjects: 68
Study 33075592 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up positioning in acute stroke unit care
Number of subjects: 11086
Study 33075592 — intervention group
Group type: COMPARATOR
Intervention: Head-down positioning in acute stroke unit care
Number of subjects: 11086
Study 36279880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of EBUS‐TBNA and transbronchial mediastinal cryobiopsy
Number of subjects: 271
Study 36279880 — intervention group
Group type: COMPARATOR
Intervention: EBUS‐TBNA alone
Number of subjects: 271
Study 33514342 — intervention group
Group type: EXPERIMENTAL
Intervention: GROW standards
Number of subjects: 225
Study 33514342 — intervention group
Group type: EXPERIMENTAL
Intervention: INTERGROWTH standards
Number of subjects: 225
Study 33514342 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO standards
Number of subjects: 225
Study 32264698 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates (PCCs) administered to patients with factor Xa inhibitor-related ICH
Number of subjects: 663
Study 36141729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully digital workflow
Number of subjects: 10
Study 36141729 — intervention group
Group type: COMPARATOR
Intervention: Conventional workflow
Number of subjects: 10
Study 32340638 — intervention group
Group type: EXPERIMENTAL
Intervention: IbET (internet-based extinction therapy)
Number of subjects: 311
Study 32340638 — intervention group
Group type: COMPARATOR
Intervention: CTRL (internet-based stress-management training program)
Number of subjects: 311
Study 32340638 — intervention group
Group type: EXPERIMENTAL
Intervention: IbET
Number of subjects: 311
Study 32340638 — intervention group
Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 311
Study 36120805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP) technology, treated biweekly for five sessions with a follow-up 30 days after final treatment
Number of subjects: 18
Study 36120805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP) technology
Number of subjects: 18
Study 36120805 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 18
Study 34008703 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with low-dose morphine (15 mcg/kg)
Number of subjects: 66
Study 34008703 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia with clonidine (1 mcg/kg)
Number of subjects: 66
Study 33759836 — intervention group
Group type: COMPARATOR
Intervention: Total Thyroidectomy (TT)
Number of subjects: 60
Study 33759836 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Thyroidectomy + Prophylactic Central Neck Dissection (TT + pCND)
Number of subjects: 60
Study 35285535 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led sexual rehabilitation programme
Number of subjects: 172
Study 35285535 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 172
Study 33049188 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 French catheter
Number of subjects: 52
Study 33049188 — intervention group
Group type: COMPARATOR
Intervention: 20 French catheter
Number of subjects: 52
Study 33739422 — intervention group
Group type: EXPERIMENTAL
Intervention: TAILORED (personalized weight loss information)
Number of subjects: 459
Study 33739422 — intervention group
Group type: EXPERIMENTAL
Intervention: TARGETED (generic weight loss information)
Number of subjects: 459
Study 33739422 — intervention group
Group type: COMPARATOR
Intervention: CONTROL (general healthy body content)
Number of subjects: 459
Study 32493459 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of expanded umbilical cord blood cells at a dose of 5 million cells/kg (maximum dose - 500 million cells)
Number of subjects: 24
Study 32493459 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive care
Number of subjects: 24
Study 35278689 — intervention group
Group type: COMPARATOR
Intervention: Occipital tACS stimulation at 10 Hz
Number of subjects: 0
Study 35278689 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipital tACS stimulation at 6 Hz
Number of subjects: 0
Study 35278689 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipital tACS stimulation at 20 Hz
Number of subjects: 0
Study 35278689 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipital tACS stimulation at 40 Hz
Number of subjects: 0
Study 35278689 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 35278689 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz tACS delivered to sensorimotor areas
Number of subjects: 0
Study 33431075 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT)
Number of subjects: 0
Study 35852479 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-temperature zone mattress with cooler centre and warmer periphery plus STS pillow (30 min after lights-off)
Number of subjects: 11
Study 35852479 — intervention group
Group type: COMPARATOR
Intervention: Control night (no intervention)
Number of subjects: 11
Study 33781956 — intervention group
Group type: EXPERIMENTAL
Intervention: Real stimulation (1 Hz)
Number of subjects: 33
Study 33781956 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 33
Study 34226144 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1225
Study 34860681 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth Resource Checklist
Number of subjects: 0
Study 34427137 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial Access (RA)
Number of subjects: 180
Study 34427137 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral Access (FA)
Number of subjects: 180
Study 34427137 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedal Access (PA)
Number of subjects: 180
Study 34837745 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel/gemcitabine (AG) followed by FOLFIRINOX (FFX)
Number of subjects: 91
Study 34673925 — intervention group
Group type: EXPERIMENTAL
Intervention: Home adaptation service (Care&Repair Cymru)
Number of subjects: 657536
Study 34673925 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 657536
Study 32225936 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern randomization method with randomness (90%, 90%)
Number of subjects: 0
Study 32225936 — intervention group
Group type: COMPARATOR
Intervention: One-dimensional periodic grid
Number of subjects: 0
Study 32225936 — intervention group
Group type: COMPARATOR
Intervention: One-dimensional aperiodic grid
Number of subjects: 0
Study 32225936 — intervention group
Group type: COMPARATOR
Intervention: Concentric rings structure
Number of subjects: 0
Study 32225936 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal grid with randomness (90%, 90%)
Number of subjects: 0
Study 34872440 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 52
Study 34872440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 32057658 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic irrigation and debridement (I&D)
Number of subjects: 204
Study 32057658 — intervention group
Group type: COMPARATOR
Intervention: Open irrigation and debridement (I&D)
Number of subjects: 204
Study 32542906 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course exercise training (4–8 weeks supervised by a physiotherapist, phone contact every 2 weeks)
Number of subjects: 136
Study 32542906 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no physiotherapist or case manager input)
Number of subjects: 136
Study 32542906 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course exercise training
Number of subjects: 136
Study 32542906 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 136
Study 32949705 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 35
Study 34991541 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-based recommendations (FBR)
Number of subjects: 123
Study 34991541 — intervention group
Group type: COMPARATOR
Intervention: Non-Food-based recommendations (non-FBR)
Number of subjects: 123
Study 34836205 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (8 g three times a day for five to seven weeks)
Number of subjects: 46
Study 34836205 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythritol (12 g three times a day for five to seven weeks)
Number of subjects: 46
Study 34836205 — intervention group
Group type: COMPARATOR
Intervention: Control group (no substance)
Number of subjects: 46
Study 32580282 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie ketogenic diet (LCKD)
Number of subjects: 91
Study 32580282 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 91
Study 36099069 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin + Metformin (Saxa+Met)
Number of subjects: 648
Study 36099069 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin + Acarbose (Saxa+Aca)
Number of subjects: 648
Study 36099069 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin + Gliclazide MR (Saxa+Gli)
Number of subjects: 648
Study 32910141 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslizumab (1.0 mg/kg IV)
Number of subjects: 8
Study 32910141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 32910141 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslizumab
Number of subjects: 8
Study 32910141 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC treatment
Number of subjects: 8
Study 32910141 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslizumab and Placebo
Number of subjects: 8
Study 36078306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative learning group
Number of subjects: 216
Study 36078306 — intervention group
Group type: COMPARATOR
Intervention: Individual learning group
Number of subjects: 216
Study 34922447 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic combination of behavioural science and evidence-based techniques in study invitation letter
Number of subjects: 2702
Study 34922447 — intervention group
Group type: COMPARATOR
Intervention: Standard invitation letter
Number of subjects: 2702
Study 32427788 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly hydrophilic polyurethane (HHP) foam dressing
Number of subjects: 20
Study 32427788 — intervention group
Group type: COMPARATOR
Intervention: Early hydrophilic polyurethane (EHP) foam dressing
Number of subjects: 20
Study 35573797 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score based on clinical factors and lymphocyte subtyping including CD8+ T-cell count ≤143 cells/mm3, high-dose corticosteroids (≥50 mg prednisolone equivalent), carbapenem/tigecycline, APACHE II score ≥15, (1,3)-β-D-glucan positivity, emergency gastrointestinal/hepatobiliary surgery.
Number of subjects: 1054